|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500102643 |
|
最近更新日期: Date of Last Refreshed on: |
2025-05-17 13:52:08 |
|
注册时间: Date of Registration: |
2025-05-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
宁夏地区早产儿救治和后遗症防治关键技术研究 |
|
Public title: |
Research on key technologies of treatment and sequelae prevention of premature infants in Ningxia |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
宁夏地区早产儿救治和后遗症防治关键技术研究 |
|
Scientific title: |
Research on key technologies of treatment and sequelae prevention of premature infants in Ningxia |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
崔莹莹 |
研究负责人: |
刘黎黎 |
|
Applicant: |
Yingying Cui |
Study leader: |
Lili Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 151 2197 3536 |
研究负责人电话:
Study leader's |
+86 138 1053 6759 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
cuiyingy20@163.com |
研究负责人电子邮件: Study leader's E-mail: |
liulili0205@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
银川市金凤区湖畔路127号 |
研究负责人通讯地址: |
银川市金凤区湖畔路127号 |
|
Applicant address: |
127 Hupan Road, Jinfeng District, Yinchuan City |
Study leader's address: |
127 Hupan Road, Jinfeng District, Yinchuan City |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京大学第一医院宁夏妇女儿童医院(宁夏回族自治区妇幼保健院) |
||
|
Applicant's institution: |
Peking University First Hospital Ningxia Women and Children’s Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital) |
||
|
研究负责人所在单位: |
北京大学第一医院宁夏妇女儿童医院(宁夏回族自治区妇幼保健院) |
||
|
Affiliation of the Leader: |
Peking University First Hospital Ningxia Women and Children’s Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital) |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KJ-LL-202412 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学第一医院宁夏妇女儿童医院(宁夏回族自治区妇幼保健院) 医学研究伦理审查委员会 |
||
|
Name of the ethic committee: |
Peking University First Hospital Ningxia Women and Children’s Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital)Medical Research Ethics Review Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-01-09 00:00:00 | ||
|
伦理委员会联系人: |
常晶晶 |
||
|
Contact Name of the ethic committee: |
Jingjing Chang |
||
|
伦理委员会联系地址: |
银川市金凤区湖畔路127号 |
||
|
Contact Address of the ethic committee: |
127 Hupan Road, Jinfeng District, Yinchuan City |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 136 3957 4921 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京大学第一医院宁夏妇女儿童医院(宁夏回族自治区妇幼保健院) |
||||||||||||||||||||||
|
Primary sponsor: |
Peking University First Hospital Ningxia Women and Children’s Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital) |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
银川市金凤区湖畔路127号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
127 Hupan Road, Jinfeng District, Yinchuan City |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
宁夏回族自治区科学技术厅 |
||||||||||||||||||||||
|
Source(s) of funding: |
Science and Technology Department of Ningxia Hui Autonomous Region |
||||||||||||||||||||||
|
研究疾病: |
早产儿 |
||||||||||||||||||||||
|
Target disease: |
Premature infant |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
本课题拟纳入全区分娩早产儿,通过临床、检验、影像、功能检查等综合手段,研究心、脑、肾、胃肠及五官等重要脏器并发症的发病特点及影响因素,确定宁夏地区早产儿患病基线数据,探索早期诊断的有效指标,制定疾病早期精准救治方案;出院后建立规范化随访体系,随访至校正胎龄 24个月,综合评估后遗症发生情况,探索早期预后预测的有效指标,进一步开展机制研究,指导防治策略的制定;通过信息化网络建设,建立早产儿救治和后遗症防治专项模块,覆盖宁夏有早产儿救治能力的各级医院,即时响应,保障救治,同时提取数据,建立人工智能机器学习模型辅助诊治。本项目拟建立超过万例的早产儿专病队列及临床数据库,获得宁夏地区早产儿患病基线数据,创新性的筛选疾病及后遗症预警标志物,建立诊断及预后预测模型,制定早产儿救治相关指南及专家共识。项目将覆盖宁夏,辐射西部,进一步推广至全国,整体提高我国早产儿救治水平。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study intends to include premature infants born in the whole region. Through clinical, laboratory, imaging, functional examination and other comprehensive means, the characteristics and influencing factors of complications of important organs such as heart, brain, kidney, gastrointestinal tract and facial features are studied, and the baseline data of premature infants in Ningxia are determined. Explore effective indicators for early diagnosis and formulate early and accurate treatment plans for diseases. After discharge, a standardized follow-up system was established and followed up to 24 months of corrected gestational age. The occurrence of sequelae was comprehensively evaluated, effective indicators for early prognosis prediction were explored, and further mechanism research was carried out to guide the formulation of prevention and treatment strategies. Through the construction of information network, a special module for the treatment of premature infants and the prevention and treatment of sequelae was established, covering hospitals at all levels with the ability to treat premature infants in Ningxia, to respond immediately and ensure treatment. At the same time, data were extracted and an artificial intelligence machine learning model was established to assist diagnosis and treatment. This project intends to establish a special disease cohort and clinical database of more than 10,000 premature infants, obtain baseline data of premature infants in Ningxia, innovatively screen early warning markers of diseases and sequelae, establish diagnostic and prognostic prediction models, and formulate relevant guidelines and expert consensus for the treatment of premature infants. The project will cover Ningxia, radiate the west, further promote to the whole country, and improve the treatment level of premature infants in China as a whole. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
宁夏地区所有分娩的活产早产儿(胎龄≤37周)经监护人知情同意后全部纳入本项目。 ① 活产早产儿 ② 出生胎龄24-36周 ③ 规律随访早产儿至校正胎龄2岁 |
||||||||||||||||||||||
|
Inclusion criteria |
All live birth premature infants ( gestational age <= 37 weeks ) delivered in Ningxia were included in this project with the informed consent of the guardian. 1. Live birth premature infants 2. The gestational age at birth was 24-36 weeks. 3. Regular follow-up of premature infants to corrected gestational age of 2 years old |
||||||||||||||||||||||
|
排除标准: |
符合下列标准之一者除外:①临床资料不完整,明确存在医疗纠纷;②随访期间退出的早产儿;③因各种原因死亡的早产儿。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. The clinical data is incomplete, there is a clear medical dispute; 2. Premature infants withdrawn during follow-up; 3. Premature infants who died of various causes. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-08-01 00:00:00至 To 2027-08-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-05-30 00:00:00 至 To 2027-08-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2027年8月 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
August 2027 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据收集和管理由两部分组成,一为病例记录表,二为电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection and management consist of two parts: a case record form and an electronic collection and management system |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |